Antifibrotics in systemic sclerosis
Author:
Funder
Ministerio de Economía, Industria y Competitividad, Gobierno de España
Instituto de Salud Carlos III
Publisher
Elsevier BV
Subject
Rheumatology
Reference58 articles.
1. Systemic sclerosis;Denton;Lancet,2017
2. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities;Varga;J Scleroderma Relat Disord,2017
3. Cyclophosphamide versus placebo in scleroderma lung disease;Tashkin;N Engl J Med,2006
4. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial;Tashkin;Lancet Respir Med,2016
5. Mapping and predicting mortality from systemic sclerosis;Elhai;Ann Rheum Dis,2017
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Progress in research on mesenchymal stem cells and their extracellular vesicles for treating fibrosis in systemic sclerosis;Clinical and Experimental Medicine;2023-07-17
2. Management of Connective Tissue Disease–related Interstitial Lung Disease;Current Pulmonology Reports;2022-05-03
3. Serine/threonine kinase inhibition as antifibrotic therapy: transforming growth factor-β and Rho kinase inhibitors;Rheumatology;2021-10-19
4. Relevance of immunomodulatory therapy for interstitial lung disease in systemic sclerosis;Best Practice & Research Clinical Rheumatology;2021-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3